Momenta Revenues Down $MNTA $XHS

Momenta Pharmaceuticals Inc., has announced its results for the first quarter of FY-2015. The Results shows Revenues down to $8.6 Million by -20.4% and Loss Per Share down to -$0.40 up by +24.5%. View the full earnings release here.